InvestorsHub Logo

kevindenver

11/12/19 9:33 PM

#285145 RE: DD8 #285142

How will the continuing losses and cost of clinical OTC drug development be paid for?

We all know the sector is in a capital crunch and OneQor came to TRTC for "financing help" per the call.